Jing Yu

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

Mark Pimentel, Anthony Lembo, William D. Chey et al. · New England Journal of Medicine · 2011 · 1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

From Target Selection to the Minimum Acceptable Biological Effect Level for Human Study: Use of Mechanism-based PK/PD Modeling to Design Safe and Efficacious Biologics

Jing Yu, Hélène Karcher, Adam L. Feire et al. · The AAPS Journal · 2011 · 29 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Modeling Viral Kinetics and Treatment Outcome During Alisporivir Interferon-Free Treatment in Hepatitis C Virus Genotype 2 and 3 Patients

Jérémie Guedj, Jing Yu, Micha Levi et al. · Hepatology · 2013 · 28 citations

Medicine, Infectious Diseases, Pharmacology +17

A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers

Kiran Dole, Florencia Segal, Adam L. Feire et al. · Antimicrobial Agents and Chemotherapy · 2016 · 26 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Deciphering the tumor immune microenvironment of imatinib-resistance in advanced gastrointestinal stromal tumors at single-cell resolution

Xuechao Liu, Jing Yu, Yi Li et al. · Cell Death and Disease · 2024 · 19 citations · Full text

Medicine, Immunology, Oncology +17